Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: medical treatment

Danujan Sriranganathan; Jonathan P Segal; Mayur Garg

doi:10.1136/flgastro-2021-101881

Biologics recommendations in the ECCO guidelines on therapeutics in Crohn's disease: medical treatment

Frontline Gastroenterol. 2021 Jun 23;13(2):168-170. doi: 10.1136/flgastro-2021-101881. eCollection 2022.

Authors

Danujan Sriranganathan¹, Jonathan P Segal¹, Mayur Garg^{2

3}

Affiliations

¹ Department of Gastroenterology, Hillingdon Hospitals NHS Foundation Trust, Uxbridge, UK.
² Department of Gastroenterology, Northern Health, Epping, Victoria, Australia.
³ Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.

Abstract

In 2019, the European Crohn's and Colitis Organisation released guidelines for the medical management of Crohn's disease, concerning the induction of remission, the maintenance of remission and the treatment of fistulising perianal disease. This review summarises the key recommendations regarding the use of biologics in these settings.

Keywords: Crohn's disease.